Mednet

What Mednet does

Mednet (legal name MedNet Solutions, Inc.) is a US-based eClinical technology company founded around 2001 in Minnetonka, Minnesota, that builds and sells the iMednet eClinical Platform, a unified SaaS platform combining electronic data capture (EDC), randomization and trial supply management (RTSM), clinical trial management system (CTMS), electronic consent (eConsent), electronic patient-reported outcomes (ePRO), electronic trial master file (eTMF), clinical adjudication, DICOM imaging, pharmacovigilance and safety reporting, site payments, risk-based quality management (RBQM), and decentralized trial support within a single integrated system. The platform is built on a modern React-based user interface, supports bidirectional API integrations with external labs, imaging systems, and data warehouses, and is compliant with FDA 21 CFR Part 11, HIPAA, EU GDPR, EU MDR, FDA ICH GCP, CCPA, and the EU-U.S. Data Privacy Framework, with AES-256 encryption at rest and TLS 1.2 in transit. Mednet reports that the platform has supported over 8,000 studies, 185,000+ site users, 560,000+ clinical trial participants across 100+ countries, and has been involved in over 100 FDA drug and device approvals.

Mednet sells primarily through a direct enterprise sales motion targeting pharmaceutical, biotechnology, medical device, IVD, and academic sponsors, supplemented by a CRO partner channel (including SDC and MedTrials). Pricing is quote-based and modular, marketed as 'Enterprise Power without Enterprise Pricing' with annual billing and support for unlimited users and sites within the SaaS subscription. The company maintains a headcount of 51-100 employees and has raised approximately $20.5M across funding rounds in 2014 and 2016, led by Arrowroot Capital Management. On November 18, 2025, Mednet was acquired by CRScube, South Korea's leading eClinical provider; the combined organization now serves 1,000+ clients across Asia, Europe, and North America and is positioning itself as a unified global eClinical platform with an expanding AI-driven product roadmap.

Name

Mednet

Legal name

MedNet Solutions, Inc.

Website

https://mednetsolutions.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

51–100 employees

Short description

Mednet provides the iMednet eClinical Platform, a unified SaaS suite covering EDC, RTSM, CTMS, ePRO, eConsent, eTMF, pharmacovigilance, DICOM imaging, and related modules, sold primarily to pharmaceutical, biotech, medical device, and CRO customers across 100+ countries.

Ownership category

akta.pro rank

Product category

eClinical Solutions

NAICS

Computer Systems Design Services (541512), Other Computer Related Services (541519)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• EClinical solutions
• Electronic data capture
• Clinical trial software
• Randomization trial supply management
• Clinical trial management system

Headquarters

HQ city

Minnetonka

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Subscription (iMednet Platform): Mednet operates as a Software-as-a-Service (SaaS) provider offering its iMednet eClinical platform on a subscription basis. The platform uses a flexible, modular pricing model — customers can implement only the modules required for their study. The model supports unlimited users and sites as part of enterprise power pricing, and is described as 'Enterprise Power – Without Enterprise Pricing'.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Mednet develops and sells the iMednet eClinical Platform, a unified SaaS platform that combines Electronic Data Capture (EDC), Randomization & Trial Supply Management (RTSM), Clinical Trial Management System (CTMS), eConsent, ePRO, eTMF, pharmacovigilance, adjudication, DICOM imaging, API integration, and Risk-Based Quality Management (RBQM) modules. The platform is designed to help pharmaceutical, biotechnology, medical device sponsors, and Contract Research Organizations (CROs) accelerate study startup, improve data quality, and execute clinical trials from Phase I through submission-ready results.

Product overview

Mednet offers the iMednet eClinical Platform, a unified, modular SaaS platform designed to support the complete clinical trial lifecycle. The platform combines a core EDC module with integrated add-on modules including RTSM (Randomization & Trial Supply Management), CTMS (Clinical Trial Management System), eConsent, ePRO, eTMF, Adjudication, DICOM Imaging, Site Payments, Pharmacovigilance, API Integration, RBQM, and Virtual/Decentralized Trials. This integrated architecture eliminates silos by connecting data, workflows, and stakeholders within a single environment, enabling sponsors and CROs to accelerate study startup, improve data quality, and maintain continuity across all phases of clinical development from Phase I studies through submission-ready results.

Differentiator

Problem solved

Functional benefit

Products and services

• iMednet eClinical Platform
• Electronic Data Capture (EDC)
• Randomization & Trial Supply Management (RTSM)
• Clinical Trial Management System (CTMS)
• ePRO (Electronic Patient-Reported Outcomes)
• eConsent
• eTMF (Electronic Trial Master File)
• Clinical Adjudication
• DICOM Imaging
• Site Payments
• Pharmacovigilance & Safety Reporting
• API Integration
• Risk-Based Quality Management (RBQM)
• Virtual and Decentralized Trials

Quantifiable outcome

• Phase I study builds completed in a month or less; some builds completed in as little as a few days
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature15 records

Partnerships

Three partnerships are on record, tiered core.

• CRScubecoreStrategic or Co-development Partner · 18 November 2025CRScube, Korea's leading eClinical solutions provider, acquired Mednet in November 2025 to expand into the North American market. The transaction combines CRScube's strong Asian market position (supporting 6,000+ trials worldwide) with Mednet's established North American presence (having supported over 100 FDA approvals). Both companies will continue serving existing clients while working to align operations and explore integration opportunities, creating a unified global eClinical platform.
• MedTrials, Inc.coreStrategic or Co-development Partner · 9 June 2020Mednet and MedTrials co-presented webinars on clinical trial transformation, including 'The Pandemic Push: Driving Disruption and Transformation in Clinical Trial Management' (June 2020). MedTrials is a clinical trial management consultancy and CRO. The partnership combined Mednet's eClinical technology with MedTrials' operational expertise to drive innovation in clinical trial management.
• Statistics & Data Corporation (SDC)coreChannel Partner/ Reseller/ DistributorSDC is a long-standing CRO partner of Mednet. The partnership optimized clinical trials and delivered value to sponsors through collaboration, with SDC achieving over 50% labor reduction after transitioning to the iMednet platform. SDC's feedback has informed platform evolution and feature enhancements over the partnership.

Scale indicators10 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Advarra: Advarra offers CTMS, eRegulatory, and eSource solutions for sites, sponsors, and CROs, with a strong presence in academic and mid-market trials. A direct competitor in the CTMS and clinical operations layer, often overlapping on RFPs with Mednet.
• ArisGlobal: ArisGlobal provides life sciences R&D technology including pharmacovigilance, regulatory, and clinical trial software (with EDC and CTMS capabilities). Comparable where Mednet's pharmacovigilance and safety reporting modules overlap, particularly for mid-sized pharma sponsors.
• Bio-Optronics: Bio-Optronics provides CTMS (Clinical Conductor), EDC, and operational software for academic medical centers and mid-sized sponsors. Comparable as a similarly positioned mid-market eClinical platform targeting the same academic and CRO-adjacent segments.
• Clario: Clario (formed via the merger of Bioclinica and ERT) delivers eCOA, EDC, imaging, and respiratory/cardiac safety services for clinical trials. Direct peer in EDC, eCOA/ePRO, and imaging endpoints where Mednet's DICOM and ePRO modules overlap.
• Signant Health: Signant provides eCOA, EDC, RTSM, patient engagement, and clinical supply solutions for global trials. Comparable to Mednet as a similarly sized eClinical specialist targeting pharma and CRO customers with a unified platform approach.
• Clinical Ink: Clinical Ink offers EDC, eCOA, ePRO, and risk-based monitoring solutions focused on mid-to-large pharma and CROs. A direct competitor to Mednet in the modular eClinical platform category serving sponsors running Phase I–IV trials.

Broad incumbents

• IQVIA (Clinical Technologies): IQVIA delivers EDC, CTMS, RBQM, and clinical analytics as part of its broader CRO and technology stack. Comparable as a broad incumbent that competes both as a CRO partner channel and as a software suite across the same sponsors Mednet serves.
• Medidata (Oracle): Medidata's Rave EDC, RTSM, CTMS, ePRO, and imaging modules are the most direct full-suite competitor to iMednet, now backed by Oracle's enterprise scale. Comparable as the category leader that Mednet positions against for unified clinical trial platforms.
• Veeva Systems: Veeva is the largest pure-play life sciences cloud software vendor, offering Veeva Vault CTMS, eTMF, and a broader clinical-to-commercial suite. It competes with Mednet at the enterprise end of the eClinical market and sets the ceiling on pricing and feature expectations for regulated buyers.

Emerging players

• Castor: Castor offers a modular eClinical platform (EDC, eConsent, ePRO, decentralized trials) targeted at academic and mid-market sponsors. It competes with Mednet for the same underserved mid-market and academic segments where modular SaaS pricing matters most.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/mednet-solutions
• Xx.com/MedNetSolutions

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mednet